U.S., Nov. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07254000) titled 'Anakinra Pilot 2 - A Study to Optimise Dose and Route of Administration of Anakinra in Preterm Infants' on April 07.
Brief Summary: A phase 2 randomised, three-arm, parallel-group, dose-ranging trial to determine safety, efficacy and optimal dosing of intravenous anakinra in premature neonates, with subcutaneous pharmacokinetic sub-study.
Study Start Date: June 27
Study Type: INTERVENTIONAL
Condition:
Premature Infants
Very Premature Infants
Inflammation
Intervention:
DRUG: Anakinra (Kineret(R))
Standard care plus Anakinra for 21 days
Recruitment Status: RECRUITING
Sponsor: Monash Medical Centre
Disclaimer: Curated by HT S...